Medical translation agency Conversis Medical has named Dr Mark Hooper as global director.
Dr Hooper has worked in the pharma services field for the past 13 years and has experience in both the contract research organisation (CRO) and contract manufacturing organisation (CMO) environments.
Gary Muddyman, founder of Conversis Medical, explained: “We aim to provide the pharmaceutical industry with a service that encompasses the unique requirements of this sector and Mark’s appointment will help us achieve this.
“Mark’s deep understanding of the pharma market will give us a real competitive advantage.”
Dr Hooper said: “Medical translation requires specialist knowledge of the translation/localisation process, in direct combination with the regulatory requirements of medicines and the specific scientific terms used for drug products.
“Language works only when the speaker and the audience, and the translators, share the same background knowledge and understand the context of communication.”